🎉 FOUNDING MEMBER OFFER — $1,800 $1,200
⏰ Limited to first 120 cards • Offer ends 20 November 2026
by NextGen Molecular Lab
The MyDNAid platform was born from a critical clinical observation. During our initial whole genome sequencing work at NextGen Molecular Lab, we repeatedly identified hidden genetic mutations that confer resistance or incompatibility to critical, life-saving drugs. These variations drastically impact treatment response, often leading to adverse reactions or therapeutic failure. MyDNAid was created to decode these variations, ensuring your medications are as unique as your DNA.
Pay $1,800 $1,200 once for sequencing + initial analysis. All future re-analyses from $100 - $150 per condition.
Direct-to-consumer pharmacogenomics. Discover how your DNA affects your response to anesthesia, painkillers, antidepressants, and cardiac drugs. Includes your encrypted physical wallet card and lifetime data storage.
$1,800 USD
$1,200 USD
One-time sequencing + PGx analysis
Comprehensive clinical genetic screening for hereditary cancers, cardiomyopathies, and rare diseases. Requires Genetic Counseling & Doctor's Referral.
$1,800 USD
$1,200 USD
One-time sequencing + doctor's requested clinical analysis
Your raw genomic data, deep ancestry insights, and trait analysis. Unlock the full potential of your genome for personal knowledge and future research. Requires Genetic Counseling.
$1,800 USD
$1,200 USD
One-time sequencing + requested hereditary condition analysis
For re-analysis contact us on orders@nextgenmolecularlab.com
The myDNAid PGx card is a secure, portable genetic passport that puts your pharmacogenomic data in your hands—ready for any medical emergency, anywhere in the world.
Encrypted Physical Card
Your complete PGx data encrypted on a wallet-sized card
Instant Doctor Access
QR code for emergency access with OTP security
Lifetime Data Storage
Future re-analysis options for comprehensive testing